Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT06785961
Active, not recruiting Phase 1

Healing Assessment of External Inflammatory Root Resorption After Revascularization Technique of Avulsed Permanent Central Incisor (Case Study)

NCT06785961 · tracked via the Priya Life Science Egypt tracker
Sponsor
Badr University
Phase
Phase 1
Started
2024-11-27
Last updated
2025-01-21

Condition(s) studied

Avulsion

Investigational drug(s) / intervention(s)

Regeneration of traumatic tooth

Regeneration of traumatic tooth: Revascularization is a new treatment method for immature necrotic , pulp revascularization allows also the stimulation of the apical development and the root maturation of immature teeth ( growth and thickening of dentinal walls ).

Study summary

Evaluate the healing of external root resorption of replanted avulsed permanent maxillary central incisor after revascularization.

Eligibility

Sex
MALE
Min age
11 Months
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * traumatic teeth * external inflammatory root resorption Exclusion Criteria: \-

Primary outcome measure(s)

  • Measure amount of bone healing and root formation by using cone beam computed tomography (CBCT) — 18 months
    Measure amount of bone healing and root formation by using measuring tool cone beam computed tomography (CBCT) By using measuring unit hounsfield unit (HU)

Trial sites (1)

FacilityCityRegionStatus
Badr university in Cairo Badr Cairo Governorate

More Badr University trials in Egypt

Scooter Board Activities Versus Core Stability Exercises Enrolling by invitation
Immune Profile and Respiratory Parameters in Down Syndrome Children With Acute Pneumonia: Pre-Intervention Analysis Recruiting
Low Intensity Laser Therapy on Immune System Response Among Children With Pneumonia Recruiting
Effect of Reactive Functional Motor Challenge Training on Dynamic Balance and Functional Mobility in Children With Spastic Diplegic Cerebral Palsy: A Randomized Comparative Trial. Active, not recruiting
Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease Patients Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06785961 on ClinicalTrials.gov ↗ ← All trials in Egypt